NCT00789607 Fiducial Localization and Individualized Radiotherapy -Prostate Cancer Status COMPLETED Phase NA
NCT00788307 Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy Status TERMINATED Phase PHASE1
NCT00786682 Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT00780975 A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer Status TERMINATED Phase PHASE2
NCT00780754 Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia Status COMPLETED Phase PHASE3
NCT00779168 White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy Status COMPLETED Phase PHASE1
NCT00777959 Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002) Status COMPLETED Phase PHASE2
NCT00777452 A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer Status COMPLETED Phase N/A
NCT00776594 Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy Status COMPLETED Phase PHASE2
NCT00773773 Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer Status TERMINATED Phase NA
NCT00773318 SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer Status TERMINATED Phase NA
NCT00773305 Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer Status COMPLETED Phase N/A
NCT00771017 Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT00770848 AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00770822 Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer Status UNKNOWN Phase NA
NCT00769990 Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases Status WITHDRAWN Phase PHASE1/PHASE2